Ni Yu
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Surgery 2
- Tissue Engineering and Regenerative Medicine 1
-
- Renal and related cancers 2
- Co-authors
- Terrill K. McClanahan (2 shared papers)Erin Murphy (2 shared papers)Laura Q.M. Chow (1 shared paper)Tanguy Y. Seiwert (1 shared paper)Christina Moon (1 shared paper)Jonathan D. Cheng (1 shared paper)Jared Lunceford (1 shared paper)Jennifer H. Yearley (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)Biology of Reproduction (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ni Yu
6 papers receiving 698 citations
Ni Yu's Hit Papers
Peers
Comparison fields: 5 of 65
- Immunology 337
- Oncology 379
- Otorhinolaryngology 25
- Pulmonary and Respiratory Medicine 165
- Reproductive Medicine 34
Countries citing papers authored by Ni Yu
This map shows the geographic impact of Ni Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Yu more than expected).
Fields of papers citing papers by Ni Yu
This network shows the impact of papers produced by Ni Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Yu. The network helps show where Ni Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ni Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer Hit paper breakdown → | 2017 | 453 |
| 2 | 2009 | 181 | |
| 3 | 1999 | 42 | |
| 4 | 2019 | 25 | |
| 5 | 2023 | 6 | |
| 6 | 2024 | 1 | |
| 7 | 2025 | 0 | |
| 8 | 2023 | 0 |
About Ni Yu
Ni Yu is a scholar working on Surgery, Molecular Biology, Pharmacology, Genetics and Oncology, having authored 8 papers that have together received 708 indexed citations. Recurring topics across this work include Renal and related cancers (2 papers), Liver Disease and Transplantation (1 paper), Mesenchymal stem cell research (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Silicone and Siloxane Chemistry (1 paper), Tissue Engineering and Regenerative Medicine (1 paper), Cancer Cells and Metastasis (1 paper) and Reproductive Biology and Fertility (1 paper). The work is most often cited by research in Immunology (337 citations), Oncology (379 citations), Otorhinolaryngology (25 citations), Pulmonary and Respiratory Medicine (165 citations) and Reproductive Medicine (34 citations). Ni Yu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Terrill K. McClanahan, Erin Murphy, Laura Q.M. Chow, Tanguy Y. Seiwert, Christina Moon, Jonathan D. Cheng, Jared Lunceford, Jennifer H. Yearley, Joanne E. Tomassini and Masahisa Handa. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, The Journal of Immunology, Biology of Reproduction and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.